You Searched For "analyst report on metropolis healthcare ipo" and got 20 results
Sort By:
3 mins read
Time to buy US cannabis stocks, analyst says
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee
2 mins read
NOCD raised $33 million to bring OCD treatment online
These are Insider's biggest healthcare stories for September 22.
Lydia Ramsey Pflanzer
3 mins read
Exclusive: ‘You’re going to believe a website basis what!’ : In conversation with Metropolis MD-CEO Ameera Shah
It’s also the country’s only multinational chain of diagnostic centres with presence in UAE, Sri La…
5 mins read
China’s Fosun-owned Gland Pharma IPO opens today— Here’s all you need to know about India’s largest pharmaceutical IPO
The ₹6,500 IPO of Hyderabad-based Gland Pharma is now open for subscription. The company is backed …
6 mins read
People are flocking to sextech startups ahead of the 'hot vax summer.' VCs are taking note.
Half of adult Americans have gotten at least one COVID-19 vaccine, and that could lead to more sex …
Matt Turner,Jordan Parker Erb
4 mins read
We're on the brink of a 3rd US COVID-19 vaccine
These are the top stories written by Business Insider's healthcare team for the week ending Februar…
Lydia Ramsey Pflanzer
4 mins read
Unpacking a record deal in the hottest part of healthcare
Welcome to Dispensed, Business Insider's weekly healthcare newsletter. This week, we're focused on …
Andrew Dunn
2 mins read
One million COVID-19 vaccine doses administered in India in just six days, says Health Ministry
India took only 6 days to roll out one million vaccine doses. This count is higher than countr…
PTI
5 mins read
Dr. Fauci hasn't figured out what he's doing for the holidays yet
These are the top stories written by Business Insider's healthcare team for the week ending Septemb…
Lydia Ramsey Pflanzer
2 mins read
What's inside the $500 billion 'skinny' stimulus bill
Business Insider's biggest healthcare stories for September 9.
Lydia Ramsey Pflanzer
5 mins read
A second primary-care company is gearing up to go public
These are the top stories written by Business Insider's healthcare team for the week ending July 17.
Lydia Ramsey Pflanzer
2 mins read
Tech Mahindra rallies more than 30% in 30 days as analysts seem bullish on 5G opportunities for the blue chip stock
Shares of Tech Mahindra have gained 31% in the last 30 days as analysts remain positive on the info…
5 mins read
The future of finance, inside Peloton's IPO, and CMOs to watch
Take Thasos Group. A player in the booming $7 billion alternative-data industry, Thasos was worth $…
Matt Turner
7 mins read
Uber and Lyft's IPOs will trigger competition at Google; hedge funds cut stock-pickers; hot marijuana IPOs
I went down a bit of a rabbit hole this week after reading our reporter Dan DeFrancesco's piece abo…
Olivia Oran
7 mins read
Budget 2021: From Income Tax deductions to creating jobs and boosting healthcare – Here’s all that could be in Nirmala Sitharaman’s fiscal plans
India’s Finance Minister Nirmala Sitharaman is set to announce the annual budget on February 1, 202…
2 mins read
Default settings in Microsoft tool exposes 38 million users’ personal data, says report
"The number of accounts exposing sensitive information, however, indicates that the risk of …
5 mins read
Dispensed: What we're looking out for at the biggest healthcare investor conference, One Medical's going public, and biotech surprises
At the JPMorgan conference next week, a few sessions have caught our attention: Verily presents at …
Lydia Ramsey
2 mins read
Pharma giant GlaxoSmithKline signs mega deal with Pfizer that could change the face of global healthcare
"Ultimately, our goal is to create two exceptional, UK-based global companies, with appropriate cap…
Callum Burroughs
5 mins read
Perfecting the Poshmark 6-figure side hustle, Wall Street's most accurate analysts make predictions, and the biggest VCs in cannabis place bets
This is Drake Baer, writing in lieu of executive editor Matt Turner, who's on parental leave. I run…
Drake Baer
5 mins read
Dispensed: Amazon and Best Buy's expanding healthcare ambitions, the history of controversial e-cig startup Juul, and the lowdown on Novartis' letter to the FDA
Over the past few weeks, it's been worrisome to watch as the number of deaths connected with vaping…